Maury, S
Rosenzwajg, M
Redjoul, R
Marcais, A
Xhaard, A
Cherai, M
Cabanne, L
Churlaud, G
Suarez, F
SociƩ, G
Gregoire, L
Debbache, K
Bernard, C
Beaumont, J-L
Azar, N
Boyer, O
Roudot-Thoraval, F
Cohen, J L
Cordonnier, C
Lemoine, F M
Klatzmann, D
Article History
First Online: 8 August 2014
Competing interests
: SM, JLC, FML and DK are inventors of a patent application claiming the association of lymphodepletion with suicide gene transduction and Treg depletion of DLI. JLC, FML and DK are shareholders of LTKfarma, a company developing suicide gene-modified T cells for cancer and autoimmune diseases. The remaining authors declare no conflict of interest.